Insider Transactions in Q1 2015 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q1 2015)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
357,287
-100.0%
|
$7,860,314
$22.35 P/Share
|
|
Mar 12
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
197,277
-35.57%
|
$4,340,094
$22.59 P/Share
|
|
Mar 12
2015
|
Jeff Himawan Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
135,805
-19.67%
|
$543,220
$4.04 P/Share
|
|
Mar 12
2015
|
Jeff Himawan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
690,369
+50.0%
|
$2,761,476
$4.31 P/Share
|
|
Mar 10
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
1,284,915
-100.0%
|
$26,983,215
$21.84 P/Share
|
|
Mar 09
2015
|
Jeff Himawan Director |
SELL
Open market or private sale
|
Indirect |
329,912
-20.43%
|
$6,928,152
$21.91 P/Share
|
|
Mar 05
2015
|
Robert Carey EVP, Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,736
-29.52%
|
$194,720
$20.84 P/Share
|
|
Mar 05
2015
|
Robert Carey EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,025
+48.47%
|
-
|
|
Jan 02
2015
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,353
-22.94%
|
$316,236
$12.8 P/Share
|
|
Jan 02
2015
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
81,675
+41.55%
|
-
|
|
Jan 02
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,753
-7.88%
|
$105,036
$12.8 P/Share
|
|
Jan 02
2015
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,750
+19.41%
|
-
|